ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-212165,Epigenetic regulation of gene expression,2/11,149/10899,0.009417129487446706,0.15008665204184202,0.10947057919338665,CHD4/SAP30BP,2
R-HSA-9018519,Estrogen-dependent gene expression,2/11,150/10899,0.009539133956738865,0.15008665204184202,0.10947057919338665,TLE3/CCND1,2
R-HSA-1855167,Synthesis of pyrophosphates in the cytosol,1/11,10/10899,0.01005108609123051,0.15008665204184202,0.10947057919338665,NUDT4,1
R-HSA-196025,Formation of annular gap junctions,1/11,11/10899,0.011051126320177351,0.15008665204184202,0.10947057919338665,CLTCL1,1
R-HSA-77286,mitochondrial fatty acid beta-oxidation of saturated fatty acids,1/11,11/10899,0.011051126320177351,0.15008665204184202,0.10947057919338665,HADHA,1
R-HSA-190873,Gap junction degradation,1/11,12/10899,0.012050248069853997,0.15008665204184202,0.10947057919338665,CLTCL1,1
R-HSA-375281,Hormone ligand-binding receptors,1/11,12/10899,0.012050248069853997,0.15008665204184202,0.10947057919338665,TSHR,1
R-HSA-4641265,Repression of WNT target genes,1/11,12/10899,0.012050248069853997,0.15008665204184202,0.10947057919338665,TLE3,1
R-HSA-71064,Lysine catabolism,1/11,12/10899,0.012050248069853997,0.15008665204184202,0.10947057919338665,SLC25A21,1
R-HSA-209543,p75NTR recruits signalling complexes,1/11,13/10899,0.013048452099543528,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-193639,p75NTR signals via NF-kB,1/11,16/10899,0.01603756545315327,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-8934593,Regulation of RUNX1 Expression and Activity,1/11,17/10899,0.01703210618457074,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,1/11,17/10899,0.01703210618457074,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",1/11,17/10899,0.01703210618457074,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-8939211,ESR-mediated signaling,2/11,223/10899,0.02029712420148567,0.15008665204184202,0.10947057919338665,TLE3/CCND1,2
R-HSA-157118,Signaling by NOTCH,2/11,236/10899,0.022576089868154268,0.15008665204184202,0.10947057919338665,TLE3/CCND1,2
R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,1/11,23/10899,0.022980184440911766,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-450302,activated TAK1 mediates p38 MAPK activation,1/11,24/10899,0.023968343504092382,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,1/11,24/10899,0.023968343504092382,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-3247509,Chromatin modifying enzymes,2/11,274/10899,0.029819399329015884,0.15008665204184202,0.10947057919338665,CCND1/CHD4,2
R-HSA-4839726,Chromatin organization,2/11,274/10899,0.029819399329015884,0.15008665204184202,0.10947057919338665,CCND1/CHD4,2
R-HSA-6804758,Regulation of TP53 Activity through Acetylation,1/11,30/10899,0.02987824249355664,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-9006931,Signaling by Nuclear Receptors,2/11,299/10899,0.03503470248984504,0.15008665204184202,0.10947057919338665,TLE3/CCND1,2
R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,1/11,36/10899,0.035755592098442035,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-168638,NOD1/2 Signaling Pathway,1/11,37/10899,0.03673199718791231,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-77289,Mitochondrial Fatty Acid Beta-Oxidation,1/11,37/10899,0.03673199718791231,0.15008665204184202,0.10947057919338665,HADHA,1
R-HSA-9675126,Diseases of mitotic cell cycle,1/11,38/10899,0.03770750335905293,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-5689896,Ovarian tumor domain proteases,1/11,39/10899,0.038682111356756144,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-8853884,Transcriptional Regulation by VENTX,1/11,39/10899,0.038682111356756144,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-9031628,NGF-stimulated transcription,1/11,39/10899,0.038682111356756144,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,1/11,42/10899,0.041600553749920666,0.15008665204184202,0.10947057919338665,TLE3,1
R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation  ,1/11,45/10899,0.04451093934559358,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-190828,Gap junction trafficking,1/11,47/10899,0.04644673030065316,0.15008665204184202,0.10947057919338665,CLTCL1,1
R-HSA-69231,Cyclin D associated events in G1,1/11,47/10899,0.04644673030065316,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-69236,G1 Phase,1/11,47/10899,0.04644673030065316,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-73762,RNA Polymerase I Transcription Initiation,1/11,47/10899,0.04644673030065316,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,1/11,48/10899,0.04741328816710144,0.15008665204184202,0.10947057919338665,TLE3,1
R-HSA-157858,Gap junction trafficking and regulation,1/11,49/10899,0.04837895527890301,0.15008665204184202,0.10947057919338665,CLTCL1,1
R-HSA-1483249,Inositol phosphate metabolism,1/11,50/10899,0.0493437323749335,0.15008665204184202,0.10947057919338665,NUDT4,1
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,1/11,51/10899,0.05030762019352286,0.15008665204184202,0.10947057919338665,CLTCL1,1
R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,1/11,52/10899,0.05127061947245659,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-8848021,Signaling by PTK6,1/11,54/10899,0.053193955359778,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/11,54/10899,0.053193955359778,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-9013405,RHOD GTPase cycle,1/11,54/10899,0.053193955359778,0.15008665204184202,0.10947057919338665,ARHGAP17,1
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",1/11,57/10899,0.05607231355670961,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-9013406,RHOQ GTPase cycle,1/11,59/10899,0.05798679717442978,0.15008665204184202,0.10947057919338665,ARHGAP17,1
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/11,60/10899,0.05894271463117162,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),1/11,61/10899,0.05989775016388266,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-8943724,Regulation of PTEN gene transcription,1/11,61/10899,0.05989775016388266,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-450294,MAP kinase activation,1/11,64/10899,0.06275757253872893,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-9679506,SARS-CoV Infections,2/11,413/10899,0.06283866603490165,0.15008665204184202,0.10947057919338665,RIPK2/CHD4,2
R-HSA-448424,Interleukin-17 signaling,1/11,72/10899,0.07034514310650564,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-1980143,Signaling by NOTCH1,1/11,74/10899,0.07223328948916652,0.15008665204184202,0.10947057919338665,TLE3,1
R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,1/11,76/10899,0.07411794899103785,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-9009391,Extra-nuclear estrogen signaling,1/11,77/10899,0.07505897297339914,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-3214858,RMTs methylate histone arginines,1/11,79/10899,0.07693841301973137,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-449147,Signaling by Interleukins,2/11,473/10899,0.07977397896872912,0.15008665204184202,0.10947057919338665,CCND1/RIPK2,2
R-HSA-195253,Degradation of beta-catenin by the destruction complex,1/11,83/10899,0.08068688167018578,0.15008665204184202,0.10947057919338665,TLE3,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/11,83/10899,0.08068688167018578,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/11,85/10899,0.08255592181585458,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-9013404,RAC2 GTPase cycle,1/11,88/10899,0.08535300550721792,0.15008665204184202,0.10947057919338665,ARHGAP17,1
R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,1/11,91/10899,0.0881423346048219,0.15008665204184202,0.10947057919338665,TLE3,1
R-HSA-2682334,EPH-Ephrin signaling,1/11,92/10899,0.08907039107404313,0.15008665204184202,0.10947057919338665,CLTCL1,1
R-HSA-1912408,Pre-NOTCH Transcription and Translation,1/11,93/10899,0.08999758878831943,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-3214815,HDACs deacetylate histones,1/11,94/10899,0.09092392846288311,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-9013423,RAC3 GTPase cycle,1/11,94/10899,0.09092392846288311,0.15008665204184202,0.10947057919338665,ARHGAP17,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/11,96/10899,0.09277403655114858,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,1/11,97/10899,0.09369780639266811,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,1/11,97/10899,0.09369780639266811,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-193704,p75 NTR receptor-mediated signalling,1/11,97/10899,0.09369780639266811,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-975871,MyD88 cascade initiated on plasma membrane,1/11,97/10899,0.09369780639266811,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-202424,Downstream TCR signaling,1/11,98/10899,0.09462072105010921,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-9679191,Potential therapeutics for SARS,1/11,99/10899,0.09554278123605975,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,1/11,103/10899,0.09922249149823192,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,1/11,104/10899,0.10014028999707592,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/11,105/10899,0.1010572382888808,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,1/11,105/10899,0.1010572382888808,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-5250913,Positive epigenetic regulation of rRNA expression,1/11,106/10899,0.10197333708254563,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,1/11,106/10899,0.10197333708254563,0.15008665204184202,0.10947057919338665,CLTCL1,1
R-HSA-427413,NoRC negatively regulates rRNA expression,1/11,107/10899,0.10288858708644566,0.15008665204184202,0.10947057919338665,SAP30BP,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,1/11,108/10899,0.10380298900842944,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,1/11,108/10899,0.10380298900842944,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-1912422,Pre-NOTCH Expression and Processing,1/11,109/10899,0.10471654355582116,0.15008665204184202,0.10947057919338665,CCND1,1
R-HSA-166166,MyD88-independent TLR4 cascade ,1/11,110/10899,0.10562925143542123,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-5250941,Negative epigenetic regulation of rRNA expression,1/11,110/10899,0.10562925143542123,0.15008665204184202,0.10947057919338665,SAP30BP,1
R-HSA-73854,RNA Polymerase I Promoter Clearance,1/11,110/10899,0.10562925143542123,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/11,110/10899,0.10562925143542123,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-73864,RNA Polymerase I Transcription,1/11,112/10899,0.10745213001582621,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,1/11,113/10899,0.108362302127611,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,1/11,113/10899,0.108362302127611,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-187037,Signaling by NTRK1 (TRKA),1/11,115/10899,0.11018011551787554,0.15008665204184202,0.10947057919338665,CHD4,1
R-HSA-9020702,Interleukin-1 signaling,1/11,115/10899,0.11018011551787554,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,1/11,116/10899,0.11108775820419803,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,1/11,116/10899,0.11108775820419803,0.15008665204184202,0.10947057919338665,RIPK2,1
R-HSA-202403,TCR signaling,1/11,120/10899,0.11470991862457192,0.15294684038038167,0.11155675054681795,RIPK2,1
R-HSA-8878166,Transcriptional regulation by RUNX2,1/11,121/10899,0.11561335965761133,0.15294684038038167,0.11155675054681795,CCND1,1
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,1/11,126/10899,0.12011800541066264,0.15726790399127996,0.11470845877523944,RIPK2,1
R-HSA-1483206,Glycerophospholipid biosynthesis,1/11,129/10899,0.12281077048652089,0.15915273318151177,0.11608322022356433,HADHA,1
R-HSA-69206,G1/S Transition,1/11,131/10899,0.12460178283525591,0.15984269111189395,0.1165864634715845,CCND1,1
R-HSA-166520,Signaling by NTRKs,1/11,134/10899,0.1272820687177426,0.16164822727153313,0.11790338997011948,CHD4,1
R-HSA-6807070,PTEN Regulation,1/11,140/10899,0.13262027166267942,0.16676014357584443,0.12163193232220729,CHD4,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/11,146/10899,0.13792877400424775,0.16843225287057179,0.12285153959892513,RIPK2,1
R-HSA-73887,Death Receptor Signalling,1/11,146/10899,0.13792877400424775,0.16843225287057179,0.12285153959892513,RIPK2,1
R-HSA-8856828,Clathrin-mediated endocytosis,1/11,146/10899,0.13792877400424775,0.16843225287057179,0.12285153959892513,CLTCL1,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/11,149/10899,0.1405719339765069,0.17002510109539407,0.12401333523741966,CCND1,1
R-HSA-446652,Interleukin-1 family signaling,1/11,153/10899,0.14408468695913124,0.17262976645103462,0.12591313259586445,RIPK2,1
R-HSA-9013148,CDC42 GTPase cycle,1/11,155/10899,0.14583616421654932,0.1730952603317922,0.12625265569165117,ARHGAP17,1
R-HSA-418555,G alpha (s) signalling events,1/11,157/10899,0.14758438260924012,0.17354830177197678,0.12658309619505975,TSHR,1
R-HSA-5633007,Regulation of TP53 Activity,1/11,160/10899,0.15020061176455923,0.1750043825146699,0.1276451360239615,CHD4,1
R-HSA-69242,S Phase,1/11,163/10899,0.15280953914057893,0.17642555882594113,0.12868171717101384,CCND1,1
R-HSA-168898,Toll-like Receptor Cascades,1/11,168/10899,0.15714157506827175,0.17979261291595058,0.13113758753919313,RIPK2,1
R-HSA-8978868,Fatty acid metabolism,1/11,177/10899,0.16488852577101354,0.18697181047248856,0.1363739686827932,HADHA,1
R-HSA-9013149,RAC1 GTPase cycle,1/11,185/10899,0.17172030117084214,0.19299538273183142,0.14076745694489157,ARHGAP17,1
R-HSA-9705683,SARS-CoV-2-host interactions,1/11,202/10899,0.18606942491423772,0.2072878681062122,0.15119214582135662,RIPK2,1
R-HSA-1483257,Phospholipid metabolism,1/11,212/10899,0.19440414760703773,0.21468979779211994,0.15659098388484505,HADHA,1
R-HSA-201681,TCF dependent signaling in response to WNT,1/11,233/10899,0.21165505417791097,0.2317257920740922,0.16901674017836812,TLE3,1
R-HSA-8878171,Transcriptional regulation by RUNX1,1/11,239/10899,0.21652182123465946,0.23502795980172436,0.1714252835686013,CCND1,1
R-HSA-1257604,PIP3 activates AKT signaling,1/11,267/10899,0.238874283633825,0.25709350865674385,0.18751950900781983,CHD4,1
R-HSA-5688426,Deubiquitination,1/11,298/10899,0.26294422372612225,0.2782826367768127,0.20297448849034,RIPK2,1
R-HSA-9694516,SARS-CoV-2 Infection,1/11,298/10899,0.26294422372612225,0.2782826367768127,0.20297448849034,RIPK2,1
R-HSA-9006925,Intracellular signaling by second messengers,1/11,309/10899,0.27131740935873505,0.2847711651947054,0.20770710764305075,CHD4,1
R-HSA-195721,Signaling by WNT,1/11,332/10899,0.288546203014142,0.3002217234406184,0.2189764746189343,TLE3,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),1/11,335/10899,0.2907659211275281,0.3002217234406184,0.2189764746189343,TSHR,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/11,362/10899,0.31046191183552085,0.3179730871218641,0.2319240088414757,CHD4,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/11,374/10899,0.3190549877641652,0.3241598675683918,0.23643653830102349,SLC25A21,1
R-HSA-9012999,RHO GTPase cycle,1/11,449/10899,0.3705926799286805,0.3735338916741462,0.272449088001035,ARHGAP17,1
R-HSA-500792,GPCR ligand binding,1/11,467/10899,0.3824217248494165,0.3824217248494165,0.27893171808328765,TSHR,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,2/6,200/4383,0.027522411558981566,0.10320904334618088,0.06518465895548266,CCND1/PPIF,2
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,2/6,200/4383,0.027522411558981566,0.10320904334618088,0.06518465895548266,CCND1/PPIF,2
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,2/6,200/4383,0.027522411558981566,0.10320904334618088,0.06518465895548266,TLE3/CCND1,2
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,2/6,200/4383,0.027522411558981566,0.10320904334618088,0.06518465895548266,CCND1/RIPK2,2
HALLMARK_NOTCH_SIGNALING,HALLMARK_NOTCH_SIGNALING,1/6,32/4383,0.04303790569994692,0.12076846920735268,0.07627482265727538,CCND1,1
HALLMARK_HEDGEHOG_SIGNALING,HALLMARK_HEDGEHOG_SIGNALING,1/6,36/4383,0.04830738768294107,0.12076846920735268,0.07627482265727538,TLE3,1
HALLMARK_INTERFERON_ALPHA_RESPONSE,HALLMARK_INTERFERON_ALPHA_RESPONSE,1/6,97/4383,0.12572006696956606,0.2426015903241182,0.1532220570468115,RIPK2,1
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/6,100/4383,0.1293875148395297,0.2426015903241182,0.1532220570468115,CCND1,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,1/6,158/4383,0.1978126182376182,0.24451257632826784,0.15442899557574807,PPIF,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,1/6,161/4383,0.20122617710330581,0.24451257632826784,0.15442899557574807,CCND1,1
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,1/6,200/4383,0.24451257632826784,0.24451257632826784,0.15442899557574807,RIPK2,1
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,1/6,200/4383,0.24451257632826784,0.24451257632826784,0.15442899557574807,NUDT4,1
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,1/6,200/4383,0.24451257632826784,0.24451257632826784,0.15442899557574807,RIPK2,1
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,1/6,200/4383,0.24451257632826784,0.24451257632826784,0.15442899557574807,RIPK2,1
HALLMARK_OXIDATIVE_PHOSPHORYLATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1/6,200/4383,0.24451257632826784,0.24451257632826784,0.15442899557574807,HADHA,1
WHITFIELD_CELL_CYCLE_M_G1,WHITFIELD_CELL_CYCLE_M_G1,3/13,126/21728,5.219262565315555e-5,0.031211190140587017,0.015383089666193216,TLE3/CCND1/NUDT4,3
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,3/13,164/21728,1.1422052129732799e-4,0.03415193586790107,0.016832497875395706,CCND1/PPIF/NUDT4,3
LUI_THYROID_CANCER_PAX8_PPARG_UP,LUI_THYROID_CANCER_PAX8_PPARG_UP,2/13,46/21728,3.369732598830571e-4,0.06441105846017117,0.03174634108228821,CCND1/CHD4,2
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,2/13,52/21728,4.308432004024828e-4,0.06441105846017117,0.03174634108228821,CCND1/CHD4,2
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,3/13,293/21728,6.279694432763516e-4,0.07119422255414531,0.035089565772154004,CCND1/PPIF/TSHR,3
BEIER_GLIOMA_STEM_CELL_DN,BEIER_GLIOMA_STEM_CELL_DN,2/13,67/21728,7.14769845606784e-4,0.07119422255414531,0.035089565772154004,TLE3/CCND1,2
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,3/13,323/21728,8.333771870886576e-4,0.07119422255414531,0.035089565772154004,CCND1/CLTCL1/TSHR,3
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,2/13,90/21728,0.0012847241579157726,0.08314496535079635,0.04097974000743352,CCND1/CHD4,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,3/13,385/21728,0.0013833389846840784,0.08314496535079635,0.04097974000743352,TLE3/CCND1/NUDT4,3
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,2/13,94/21728,0.001400238892569276,0.08314496535079635,0.04097974000743352,PPIF/NUDT4,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,3/13,412/21728,0.0016803160433025363,0.08314496535079635,0.04097974000743352,CCND1/HADHA/PPIF,3
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,3/13,431/21728,0.0019116410298331752,0.08314496535079635,0.04097974000743352,HADHA/PPIF/SLC25A21,3
DITTMER_PTHLH_TARGETS_UP,DITTMER_PTHLH_TARGETS_UP,2/13,113/21728,0.0020142082817064077,0.08314496535079635,0.04097974000743352,HADHA/NUDT4,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,3/13,482/21728,0.0026287166737498533,0.08314496535079635,0.04097974000743352,CCND1/CHD4/NUDT4,3
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,2/13,141/21728,0.0031121032369069057,0.08314496535079635,0.04097974000743352,CCND1/CHD4,2
REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2/13,146/21728,0.0033319269920685855,0.08314496535079635,0.04097974000743352,CHD4/SAP30BP,2
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,2/13,148/21728,0.003421848570949658,0.08314496535079635,0.04097974000743352,TLE3/CCND1,2
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,2/13,148/21728,0.003421848570949658,0.08314496535079635,0.04097974000743352,TLE3/ARHGAP17,2
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,2/13,168/21728,0.004383075485491879,0.08314496535079635,0.04097974000743352,TLE3/CHD4,2
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,2/13,185/21728,0.005287542863961071,0.08314496535079635,0.04097974000743352,PPIF/NUDT4,2
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,2/13,193/21728,0.005740527438645423,0.08314496535079635,0.04097974000743352,CCND1/PPIF,2
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,1/13,10/21728,0.005968213162384273,0.08314496535079635,0.04097974000743352,CHD4,1
HOLLEMAN_DAUNORUBICIN_B_ALL_UP,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,1/13,10/21728,0.005968213162384273,0.08314496535079635,0.04097974000743352,CHD4,1
KEGG_LIMONENE_AND_PINENE_DEGRADATION,KEGG_LIMONENE_AND_PINENE_DEGRADATION,1/13,10/21728,0.005968213162384273,0.08314496535079635,0.04097974000743352,HADHA,1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1/13,10/21728,0.005968213162384273,0.08314496535079635,0.04097974000743352,CCND1,1
PYEON_HPV_POSITIVE_TUMORS_DN,PYEON_HPV_POSITIVE_TUMORS_DN,1/13,10/21728,0.005968213162384273,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_RUNX3_REGULATES_P14_ARF,REACTOME_RUNX3_REGULATES_P14_ARF,1/13,10/21728,0.005968213162384273,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,1/13,10/21728,0.005968213162384273,0.08314496535079635,0.04097974000743352,NUDT4,1
BIOCARTA_BTG2_PATHWAY,BIOCARTA_BTG2_PATHWAY,1/13,11/21728,0.006563222520008849,0.08314496535079635,0.04097974000743352,CCND1,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,1/13,11/21728,0.006563222520008849,0.08314496535079635,0.04097974000743352,CLTCL1,1
PID_P38_GAMMA_DELTA_PATHWAY,PID_P38_GAMMA_DELTA_PATHWAY,1/13,11/21728,0.006563222520008849,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,1/13,11/21728,0.006563222520008849,0.08314496535079635,0.04097974000743352,HADHA,1
REACTOME_GAP_JUNCTION_DEGRADATION,REACTOME_GAP_JUNCTION_DEGRADATION,1/13,12/21728,0.007157903097770091,0.08314496535079635,0.04097974000743352,CLTCL1,1
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,1/13,12/21728,0.007157903097770091,0.08314496535079635,0.04097974000743352,TSHR,1
REACTOME_LYSINE_CATABOLISM,REACTOME_LYSINE_CATABOLISM,1/13,12/21728,0.007157903097770091,0.08314496535079635,0.04097974000743352,SLC25A21,1
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,2/13,219/21728,0.007331425357827187,0.08314496535079635,0.04097974000743352,TLE3/CCND1,2
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,1/13,13/21728,0.007752255062207558,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,1/13,13/21728,0.007752255062207558,0.08314496535079635,0.04097974000743352,RIPK2,1
SA_REG_CASCADE_OF_CYCLIN_EXPR,SA_REG_CASCADE_OF_CYCLIN_EXPR,1/13,13/21728,0.007752255062207558,0.08314496535079635,0.04097974000743352,CCND1,1
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,1/13,13/21728,0.007752255062207558,0.08314496535079635,0.04097974000743352,CCND1,1
WACKER_HYPOXIA_TARGETS_OF_VHL,WACKER_HYPOXIA_TARGETS_OF_VHL,1/13,13/21728,0.007752255062207558,0.08314496535079635,0.04097974000743352,CCND1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/13,13/21728,0.007752255062207558,0.08314496535079635,0.04097974000743352,CCND1,1
WP_VALPROIC_ACID_PATHWAY,WP_VALPROIC_ACID_PATHWAY,1/13,13/21728,0.007752255062207558,0.08314496535079635,0.04097974000743352,HADHA,1
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,1/13,14/21728,0.008346278579784872,0.08314496535079635,0.04097974000743352,ARHGAP17,1
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,1/13,14/21728,0.008346278579784872,0.08314496535079635,0.04097974000743352,CCND1,1
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,1/13,14/21728,0.008346278579784872,0.08314496535079635,0.04097974000743352,HADHA,1
REACTOME_REPRESSION_OF_WNT_TARGET_GENES,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,1/13,14/21728,0.008346278579784872,0.08314496535079635,0.04097974000743352,TLE3,1
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,1/13,14/21728,0.008346278579784872,0.08314496535079635,0.04097974000743352,CHD4,1
BAKER_HEMATOPOIESIS_STAT3_TARGETS,BAKER_HEMATOPOIESIS_STAT3_TARGETS,1/13,15/21728,0.008939973816888824,0.08314496535079635,0.04097974000743352,CCND1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,1/13,15/21728,0.008939973816888824,0.08314496535079635,0.04097974000743352,NUDT4,1
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,1/13,15/21728,0.008939973816888824,0.08314496535079635,0.04097974000743352,CCND1,1
MARKS_HDAC_TARGETS_DN,MARKS_HDAC_TARGETS_DN,1/13,15/21728,0.008939973816888824,0.08314496535079635,0.04097974000743352,CCND1,1
SA_G1_AND_S_PHASES,SA_G1_AND_S_PHASES,1/13,15/21728,0.008939973816888824,0.08314496535079635,0.04097974000743352,CCND1,1
SANCHEZ_MDM2_TARGETS,SANCHEZ_MDM2_TARGETS,1/13,15/21728,0.008939973816888824,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,2/13,245/21728,0.009099953862375004,0.08314496535079635,0.04097974000743352,TLE3/CCND1,2
BIOCARTA_P53_PATHWAY,BIOCARTA_P53_PATHWAY,1/13,16/21728,0.009533340939827828,0.08314496535079635,0.04097974000743352,CCND1,1
MAINA_VHL_TARGETS_DN,MAINA_VHL_TARGETS_DN,1/13,16/21728,0.009533340939827828,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_P75NTR_SIGNALS_VIA_NF_KB,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,1/13,16/21728,0.009533340939827828,0.08314496535079635,0.04097974000743352,RIPK2,1
WP_H19_ACTION_RBE2F1_SIGNALING_AND_CDKBETACATENIN_ACTIVITY,WP_H19_ACTION_RBE2F1_SIGNALING_AND_CDKBETACATENIN_ACTIVITY,1/13,16/21728,0.009533340939827828,0.08314496535079635,0.04097974000743352,CCND1,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,2/13,253/21728,0.00967907612798193,0.08314496535079635,0.04097974000743352,CCND1/PPIF,2
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,1/13,17/21728,0.010126380114836242,0.08314496535079635,0.04097974000743352,CCND1,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,1/13,17/21728,0.010126380114836242,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,1/13,17/21728,0.010126380114836242,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,1/13,17/21728,0.010126380114836242,0.08314496535079635,0.04097974000743352,CCND1,1
SUZUKI_AMPLIFIED_IN_ORAL_CANCER,SUZUKI_AMPLIFIED_IN_ORAL_CANCER,1/13,17/21728,0.010126380114836242,0.08314496535079635,0.04097974000743352,CCND1,1
WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,1/13,17/21728,0.010126380114836242,0.08314496535079635,0.04097974000743352,HADHA,1
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,1/13,18/21728,0.010719091508070488,0.08314496535079635,0.04097974000743352,CCND1,1
KOBAYASHI_EGFR_SIGNALING_6HR_DN,KOBAYASHI_EGFR_SIGNALING_6HR_DN,1/13,18/21728,0.010719091508070488,0.08314496535079635,0.04097974000743352,CCND1,1
SCHEIDEREIT_IKK_TARGETS,SCHEIDEREIT_IKK_TARGETS,1/13,18/21728,0.010719091508070488,0.08314496535079635,0.04097974000743352,CCND1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1/13,18/21728,0.010719091508070488,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_CHROMATIN_MODIFYING_ENZYMES,REACTOME_CHROMATIN_MODIFYING_ENZYMES,2/13,272/21728,0.011119150627975192,0.08314496535079635,0.04097974000743352,CCND1/CHD4,2
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,2/13,274/21728,0.0112759745540978,0.08314496535079635,0.04097974000743352,CCND1/HADHA,2
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,1/13,19/21728,0.011311475285610273,0.08314496535079635,0.04097974000743352,CLTCL1,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,1/13,19/21728,0.011311475285610273,0.08314496535079635,0.04097974000743352,CCND1,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,2/13,281/21728,0.011832632566777537,0.08314496535079635,0.04097974000743352,CCND1/PPIF,2
BIOCARTA_GSK3_PATHWAY,BIOCARTA_GSK3_PATHWAY,1/13,20/21728,0.011903531613460028,0.08314496535079635,0.04097974000743352,CCND1,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,2/13,282/21728,0.011913138675123324,0.08314496535079635,0.04097974000743352,CCND1/TSHR,2
VANDESLUIS_NORMAL_EMBRYOS_DN,VANDESLUIS_NORMAL_EMBRYOS_DN,1/13,21/21728,0.01249526065754658,0.08314496535079635,0.04097974000743352,NUDT4,1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,2/13,295/21728,0.012981918708649879,0.08314496535079635,0.04097974000743352,TLE3/CCND1,2
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,1/13,22/21728,0.013086662583719932,0.08314496535079635,0.04097974000743352,CCND1,1
KEGG_BETA_ALANINE_METABOLISM,KEGG_BETA_ALANINE_METABOLISM,1/13,22/21728,0.013086662583719932,0.08314496535079635,0.04097974000743352,HADHA,1
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,1/13,22/21728,0.013086662583719932,0.08314496535079635,0.04097974000743352,HADHA,1
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,1/13,22/21728,0.013086662583719932,0.08314496535079635,0.04097974000743352,RIPK2,1
WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1/13,22/21728,0.013086662583719932,0.08314496535079635,0.04097974000743352,CCND1,1
BIOCARTA_CELLCYCLE_PATHWAY,BIOCARTA_CELLCYCLE_PATHWAY,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,CCND1,1
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,CCND1,1
GOLUB_ALL_VS_AML_DN,GOLUB_ALL_VS_AML_DN,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,PPIF,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,CCND1,1
MOOTHA_FFA_OXYDATION,MOOTHA_FFA_OXYDATION,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,HADHA,1
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,TLE3,1
PID_NFKAPPAB_CANONICAL_PATHWAY,PID_NFKAPPAB_CANONICAL_PATHWAY,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,RIPK2,1
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,RIPK2,1
VERNELL_RETINOBLASTOMA_PATHWAY_DN,VERNELL_RETINOBLASTOMA_PATHWAY_DN,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,CCND1,1
WILLERT_WNT_SIGNALING,WILLERT_WNT_SIGNALING,1/13,23/21728,0.013677737557755143,0.08314496535079635,0.04097974000743352,CCND1,1
BIOCARTA_WNT_PATHWAY,BIOCARTA_WNT_PATHWAY,1/13,24/21728,0.014268485745350223,0.08314496535079635,0.04097974000743352,CCND1,1
COLLER_MYC_TARGETS_UP,COLLER_MYC_TARGETS_UP,1/13,24/21728,0.014268485745350223,0.08314496535079635,0.04097974000743352,PPIF,1
REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,1/13,24/21728,0.014268485745350223,0.08314496535079635,0.04097974000743352,CCND1,1
ZHAN_MULTIPLE_MYELOMA_SPIKED,ZHAN_MULTIPLE_MYELOMA_SPIKED,1/13,24/21728,0.014268485745350223,0.08314496535079635,0.04097974000743352,CCND1,1
DELACROIX_RAR_TARGETS_DN,DELACROIX_RAR_TARGETS_DN,1/13,25/21728,0.014858907312126579,0.08314496535079635,0.04097974000743352,CCND1,1
WP_IL7_SIGNALING_PATHWAY,WP_IL7_SIGNALING_PATHWAY,1/13,25/21728,0.014858907312126579,0.08314496535079635,0.04097974000743352,CCND1,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,2/13,321/21728,0.015241328578911261,0.08314496535079635,0.04097974000743352,HADHA/PPIF,2
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,1/13,26/21728,0.0154490024236289,0.08314496535079635,0.04097974000743352,CCND1,1
BIOCARTA_CARM_ER_PATHWAY,BIOCARTA_CARM_ER_PATHWAY,1/13,26/21728,0.0154490024236289,0.08314496535079635,0.04097974000743352,CCND1,1
BIOCARTA_RACCYCD_PATHWAY,BIOCARTA_RACCYCD_PATHWAY,1/13,26/21728,0.0154490024236289,0.08314496535079635,0.04097974000743352,CCND1,1
NOJIMA_SFRP2_TARGETS_DN,NOJIMA_SFRP2_TARGETS_DN,1/13,26/21728,0.0154490024236289,0.08314496535079635,0.04097974000743352,CCND1,1
WP_PPARALPHA_PATHWAY,WP_PPARALPHA_PATHWAY,1/13,26/21728,0.0154490024236289,0.08314496535079635,0.04097974000743352,CCND1,1
WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,1/13,26/21728,0.0154490024236289,0.08314496535079635,0.04097974000743352,CCND1,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,2/13,327/21728,0.015785414420735815,0.08314496535079635,0.04097974000743352,MARCHF3/PPIF,2
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,1/13,27/21728,0.016038771245327488,0.08314496535079635,0.04097974000743352,CCND1,1
GROSS_ELK3_TARGETS_UP,GROSS_ELK3_TARGETS_UP,1/13,27/21728,0.016038771245327488,0.08314496535079635,0.04097974000743352,CCND1,1
OHM_METHYLATED_IN_ADULT_CANCERS,OHM_METHYLATED_IN_ADULT_CANCERS,1/13,27/21728,0.016038771245327488,0.08314496535079635,0.04097974000743352,CCND1,1
BIOCARTA_G1_PATHWAY,BIOCARTA_G1_PATHWAY,1/13,28/21728,0.016628213942613823,0.08314496535079635,0.04097974000743352,CCND1,1
CHIN_BREAST_CANCER_COPY_NUMBER_UP,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1/13,28/21728,0.016628213942613823,0.08314496535079635,0.04097974000743352,CCND1,1
DAIRKEE_CANCER_PRONE_RESPONSE_E2,DAIRKEE_CANCER_PRONE_RESPONSE_E2,1/13,28/21728,0.016628213942613823,0.08314496535079635,0.04097974000743352,HADHA,1
LOPES_METHYLATED_IN_COLON_CANCER_DN,LOPES_METHYLATED_IN_COLON_CANCER_DN,1/13,28/21728,0.016628213942613823,0.08314496535079635,0.04097974000743352,TSHR,1
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,1/13,28/21728,0.016628213942613823,0.08314496535079635,0.04097974000743352,CCND1,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_3,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,1/13,28/21728,0.016628213942613823,0.08314496535079635,0.04097974000743352,CCND1,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,2/13,341/21728,0.017087455109478282,0.08314496535079635,0.04097974000743352,RIPK2/PPIF,2
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,1/13,29/21728,0.017217330680804555,0.08314496535079635,0.04097974000743352,CCND1,1
KEGG_THYROID_CANCER,KEGG_THYROID_CANCER,1/13,29/21728,0.017217330680804555,0.08314496535079635,0.04097974000743352,CCND1,1
STANELLE_E2F1_TARGETS,STANELLE_E2F1_TARGETS,1/13,29/21728,0.017217330680804555,0.08314496535079635,0.04097974000743352,CCND1,1
BIOCARTA_FAS_PATHWAY,BIOCARTA_FAS_PATHWAY,1/13,30/21728,0.017806121625140503,0.08314496535079635,0.04097974000743352,RIPK2,1
PID_CDC42_REG_PATHWAY,PID_CDC42_REG_PATHWAY,1/13,30/21728,0.017806121625140503,0.08314496535079635,0.04097974000743352,ARHGAP17,1
REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,1/13,30/21728,0.017806121625140503,0.08314496535079635,0.04097974000743352,CHD4,1
SIMBULAN_PARP1_TARGETS_UP,SIMBULAN_PARP1_TARGETS_UP,1/13,31/21728,0.01839458694078633,0.08314496535079635,0.04097974000743352,CCND1,1
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,1/13,31/21728,0.01839458694078633,0.08314496535079635,0.04097974000743352,CCND1,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1/13,31/21728,0.01839458694078633,0.08314496535079635,0.04097974000743352,HADHA,1
CAFFAREL_RESPONSE_TO_THC_DN,CAFFAREL_RESPONSE_TO_THC_DN,1/13,32/21728,0.018982726792828974,0.08314496535079635,0.04097974000743352,PPIF,1
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,1/13,32/21728,0.018982726792828974,0.08314496535079635,0.04097974000743352,RIPK2,1
STAEGE_EWING_FAMILY_TUMOR,STAEGE_EWING_FAMILY_TUMOR,1/13,32/21728,0.018982726792828974,0.08314496535079635,0.04097974000743352,CCND1,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,TLE3,1
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,CCND1,1
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,MARCHF3,1
DORN_ADENOVIRUS_INFECTION_12HR_DN,DORN_ADENOVIRUS_INFECTION_12HR_DN,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,CCND1,1
KEGG_PROPANOATE_METABOLISM,KEGG_PROPANOATE_METABOLISM,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,HADHA,1
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,CCND1,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,CCND1,1
WP_WHITE_FAT_CELL_DIFFERENTIATION,WP_WHITE_FAT_CELL_DIFFERENTIATION,1/13,33/21728,0.01957054134628078,0.08314496535079635,0.04097974000743352,TLE3,1
KEGG_BUTANOATE_METABOLISM,KEGG_BUTANOATE_METABOLISM,1/13,34/21728,0.020158030766077584,0.08314496535079635,0.04097974000743352,HADHA,1
WP_FATTY_ACID_BETAOXIDATION,WP_FATTY_ACID_BETAOXIDATION,1/13,34/21728,0.020158030766077584,0.08314496535079635,0.04097974000743352,HADHA,1
PID_ARF6_PATHWAY,PID_ARF6_PATHWAY,1/13,35/21728,0.020745195217080292,0.08314496535079635,0.04097974000743352,TSHR,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1/13,35/21728,0.020745195217080292,0.08314496535079635,0.04097974000743352,CCND1,1
PID_PI3K_PLC_TRK_PATHWAY,PID_PI3K_PLC_TRK_PATHWAY,1/13,36/21728,0.02133203486407098,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_NOD1_2_SIGNALING_PATHWAY,REACTOME_NOD1_2_SIGNALING_PATHWAY,1/13,36/21728,0.02133203486407098,0.08314496535079635,0.04097974000743352,RIPK2,1
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,1/13,36/21728,0.02133203486407098,0.08314496535079635,0.04097974000743352,CCND1,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,2/13,385/21728,0.021468711226346467,0.08314496535079635,0.04097974000743352,MARCHF3/PPIF,2
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,2/13,386/21728,0.021573268624327055,0.08314496535079635,0.04097974000743352,PPIF/CLTCL1,2
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,1/13,37/21728,0.02191854987175923,0.08314496535079635,0.04097974000743352,CCND1,1
PID_FRA_PATHWAY,PID_FRA_PATHWAY,1/13,37/21728,0.02191854987175923,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,1/13,37/21728,0.02191854987175923,0.08314496535079635,0.04097974000743352,HADHA,1
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,1/13,37/21728,0.02191854987175923,0.08314496535079635,0.04097974000743352,CCND1,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,2/13,390/21728,0.021993671143169177,0.08314496535079635,0.04097974000743352,ARHGAP17/SAP30BP,2
DORN_ADENOVIRUS_INFECTION_32HR_DN,DORN_ADENOVIRUS_INFECTION_32HR_DN,1/13,38/21728,0.022504740404776125,0.08314496535079635,0.04097974000743352,CCND1,1
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,1/13,38/21728,0.022504740404776125,0.08314496535079635,0.04097974000743352,TSHR,1
PID_RAC1_REG_PATHWAY,PID_RAC1_REG_PATHWAY,1/13,38/21728,0.022504740404776125,0.08314496535079635,0.04097974000743352,ARHGAP17,1
REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1/13,38/21728,0.022504740404776125,0.08314496535079635,0.04097974000743352,CCND1,1
DORN_ADENOVIRUS_INFECTION_48HR_DN,DORN_ADENOVIRUS_INFECTION_48HR_DN,1/13,39/21728,0.02309060662767759,0.08314496535079635,0.04097974000743352,CCND1,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,1/13,39/21728,0.02309060662767759,0.08314496535079635,0.04097974000743352,HADHA,1
PID_ECADHERIN_NASCENT_AJ_PATHWAY,PID_ECADHERIN_NASCENT_AJ_PATHWAY,1/13,39/21728,0.02309060662767759,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_NGF_STIMULATED_TRANSCRIPTION,REACTOME_NGF_STIMULATED_TRANSCRIPTION,1/13,39/21728,0.02309060662767759,0.08314496535079635,0.04097974000743352,CHD4,1
REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1/13,39/21728,0.02309060662767759,0.08314496535079635,0.04097974000743352,RIPK2,1
WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,1/13,39/21728,0.02309060662767759,0.08314496535079635,0.04097974000743352,CHD4,1
KEGG_TRYPTOPHAN_METABOLISM,KEGG_TRYPTOPHAN_METABOLISM,1/13,40/21728,0.0236761487049445,0.08314496535079635,0.04097974000743352,HADHA,1
PID_FOXM1_PATHWAY,PID_FOXM1_PATHWAY,1/13,40/21728,0.0236761487049445,0.08314496535079635,0.04097974000743352,CCND1,1
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1/13,40/21728,0.0236761487049445,0.08314496535079635,0.04097974000743352,CCND1,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/13,408/21728,0.02392812161783116,0.08314496535079635,0.04097974000743352,PPIF/CHD4,2
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1/13,41/21728,0.024261366800980788,0.08314496535079635,0.04097974000743352,CCND1,1
WP_BLADDER_CANCER,WP_BLADDER_CANCER,1/13,41/21728,0.024261366800980788,0.08314496535079635,0.04097974000743352,CCND1,1
WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,1/13,41/21728,0.024261366800980788,0.08314496535079635,0.04097974000743352,RIPK2,1
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,2/13,414/21728,0.02458827413382616,0.08314496535079635,0.04097974000743352,TLE3/RIPK2,2
DORN_ADENOVIRUS_INFECTION_24HR_DN,DORN_ADENOVIRUS_INFECTION_24HR_DN,1/13,42/21728,0.024846261080115117,0.08314496535079635,0.04097974000743352,CCND1,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/13,42/21728,0.024846261080115117,0.08314496535079635,0.04097974000743352,CCND1,1
KEGG_FATTY_ACID_METABOLISM,KEGG_FATTY_ACID_METABOLISM,1/13,42/21728,0.024846261080115117,0.08314496535079635,0.04097974000743352,HADHA,1
REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,1/13,42/21728,0.024846261080115117,0.08314496535079635,0.04097974000743352,TLE3,1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1/13,42/21728,0.024846261080115117,0.08314496535079635,0.04097974000743352,HADHA,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,2/13,422/21728,0.02548025561585504,0.08314496535079635,0.04097974000743352,CCND1/PPIF,2
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,2/13,423/21728,0.025592694155560845,0.08314496535079635,0.04097974000743352,PPIF/CLTCL1,2
CORONEL_RFX7_DIRECT_TARGETS_UP,CORONEL_RFX7_DIRECT_TARGETS_UP,1/13,44/21728,0.026015078844613515,0.08314496535079635,0.04097974000743352,CCND1,1
KEGG_LYSINE_DEGRADATION,KEGG_LYSINE_DEGRADATION,1/13,44/21728,0.026015078844613515,0.08314496535079635,0.04097974000743352,HADHA,1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,1/13,44/21728,0.026015078844613515,0.08314496535079635,0.04097974000743352,HADHA,1
SHIPP_DLBCL_CURED_VS_FATAL_DN,SHIPP_DLBCL_CURED_VS_FATAL_DN,1/13,44/21728,0.026015078844613515,0.08314496535079635,0.04097974000743352,HADHA,1
VANHARANTA_UTERINE_FIBROID_UP,VANHARANTA_UTERINE_FIBROID_UP,1/13,44/21728,0.026015078844613515,0.08314496535079635,0.04097974000743352,CCND1,1
WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,1/13,44/21728,0.026015078844613515,0.08314496535079635,0.04097974000743352,RIPK2,1
WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,WP_HEDGEHOG_SIGNALING_PATHWAY_WP4249,1/13,44/21728,0.026015078844613515,0.08314496535079635,0.04097974000743352,CCND1,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,2/13,427/21728,0.02604452835021114,0.08314496535079635,0.04097974000743352,PPIF/SAP30BP,2
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1/13,45/21728,0.026599002658255544,0.08314496535079635,0.04097974000743352,CCND1,1
PID_ILK_PATHWAY,PID_ILK_PATHWAY,1/13,45/21728,0.026599002658255544,0.08314496535079635,0.04097974000743352,CCND1,1
NAKAMURA_CANCER_MICROENVIRONMENT_DN,NAKAMURA_CANCER_MICROENVIRONMENT_DN,1/13,46/21728,0.027182603311552977,0.08314496535079635,0.04097974000743352,RIPK2,1
NUTT_GBM_VS_AO_GLIOMA_DN,NUTT_GBM_VS_AO_GLIOMA_DN,1/13,46/21728,0.027182603311552977,0.08314496535079635,0.04097974000743352,PPIF,1
PID_PS1_PATHWAY,PID_PS1_PATHWAY,1/13,46/21728,0.027182603311552977,0.08314496535079635,0.04097974000743352,CCND1,1
STOSSI_RESPONSE_TO_ESTRADIOL,STOSSI_RESPONSE_TO_ESTRADIOL,1/13,46/21728,0.027182603311552977,0.08314496535079635,0.04097974000743352,TLE3,1
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/13,47/21728,0.027765880968454892,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1/13,47/21728,0.027765880968454892,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,1/13,47/21728,0.027765880968454892,0.08314496535079635,0.04097974000743352,CHD4,1
BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,1/13,48/21728,0.028348835792836424,0.08314496535079635,0.04097974000743352,CCND1,1
HOFMANN_CELL_LYMPHOMA_UP,HOFMANN_CELL_LYMPHOMA_UP,1/13,48/21728,0.028348835792836424,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_INOSITOL_PHOSPHATE_METABOLISM,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,1/13,48/21728,0.028348835792836424,0.08314496535079635,0.04097974000743352,NUDT4,1
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/13,48/21728,0.028348835792836424,0.08314496535079635,0.04097974000743352,TLE3,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,2/13,450/21728,0.02870644577309124,0.08314496535079635,0.04097974000743352,HADHA/SLC25A21,2
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,2/13,451/21728,0.02882462229092211,0.08314496535079635,0.04097974000743352,PPIF/CHD4,2
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/13,49/21728,0.02893146794849555,0.08314496535079635,0.04097974000743352,TSHR,1
PID_ARF6_TRAFFICKING_PATHWAY,PID_ARF6_TRAFFICKING_PATHWAY,1/13,49/21728,0.02893146794849555,0.08314496535079635,0.04097974000743352,TSHR,1
WP_RETT_SYNDROME_CAUSING_GENES,WP_RETT_SYNDROME_CAUSING_GENES,1/13,49/21728,0.02893146794849555,0.08314496535079635,0.04097974000743352,CHD4,1
ZHANG_PROLIFERATING_VS_QUIESCENT,ZHANG_PROLIFERATING_VS_QUIESCENT,1/13,49/21728,0.02893146794849555,0.08314496535079635,0.04097974000743352,CCND1,1
BURTON_ADIPOGENESIS_7,BURTON_ADIPOGENESIS_7,1/13,50/21728,0.029513777599155966,0.08314496535079635,0.04097974000743352,CCND1,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/13,50/21728,0.029513777599155966,0.08314496535079635,0.04097974000743352,CCND1,1
WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,1/13,50/21728,0.029513777599155966,0.08314496535079635,0.04097974000743352,CCND1,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,2/13,459/21728,0.029777263843967,0.08314496535079635,0.04097974000743352,RIPK2/PPIF,2
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,1/13,51/21728,0.030095764908465994,0.08314496535079635,0.04097974000743352,TSHR,1
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,1/13,51/21728,0.030095764908465994,0.08314496535079635,0.04097974000743352,CLTCL1,1
REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,1/13,51/21728,0.030095764908465994,0.08314496535079635,0.04097974000743352,CLTCL1,1
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1/13,51/21728,0.030095764908465994,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/13,463/21728,0.03025837906628746,0.08314496535079635,0.04097974000743352,CCND1/RIPK2,2
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,1/13,52/21728,0.0306774300399959,0.08314496535079635,0.04097974000743352,ARHGAP17,1
KEGG_AUTOIMMUNE_THYROID_DISEASE,KEGG_AUTOIMMUNE_THYROID_DISEASE,1/13,52/21728,0.0306774300399959,0.08314496535079635,0.04097974000743352,TSHR,1
KEGG_ENDOMETRIAL_CANCER,KEGG_ENDOMETRIAL_CANCER,1/13,52/21728,0.0306774300399959,0.08314496535079635,0.04097974000743352,CCND1,1
WP_SYNAPTIC_VESICLE_PATHWAY,WP_SYNAPTIC_VESICLE_PATHWAY,1/13,52/21728,0.0306774300399959,0.08314496535079635,0.04097974000743352,CLTCL1,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,2/13,467/21728,0.030742670005542823,0.08314496535079635,0.04097974000743352,CCND1/NUDT4,2
KRIEG_HYPOXIA_VIA_KDM3A,KRIEG_HYPOXIA_VIA_KDM3A,1/13,53/21728,0.03125877315724457,0.08314496535079635,0.04097974000743352,MARCHF3,1
REACTOME_RHOD_GTPASE_CYCLE,REACTOME_RHOD_GTPASE_CYCLE,1/13,53/21728,0.03125877315724457,0.08314496535079635,0.04097974000743352,ARHGAP17,1
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,1/13,53/21728,0.03125877315724457,0.08314496535079635,0.04097974000743352,CCND1,1
WP_WNT_SIGNALING_PATHWAY,WP_WNT_SIGNALING_PATHWAY,1/13,53/21728,0.03125877315724457,0.08314496535079635,0.04097974000743352,CCND1,1
BECKER_TAMOXIFEN_RESISTANCE_DN,BECKER_TAMOXIFEN_RESISTANCE_DN,1/13,54/21728,0.03183979442363272,0.08314496535079635,0.04097974000743352,CCND1,1
BORLAK_LIVER_CANCER_EGF_UP,BORLAK_LIVER_CANCER_EGF_UP,1/13,54/21728,0.03183979442363272,0.08314496535079635,0.04097974000743352,CCND1,1
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,1/13,54/21728,0.03183979442363272,0.08314496535079635,0.04097974000743352,SAP30BP,1
KEGG_NON_SMALL_CELL_LUNG_CANCER,KEGG_NON_SMALL_CELL_LUNG_CANCER,1/13,54/21728,0.03183979442363272,0.08314496535079635,0.04097974000743352,CCND1,1
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,1/13,54/21728,0.03183979442363272,0.08314496535079635,0.04097974000743352,CCND1,1
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1/13,54/21728,0.03183979442363272,0.08314496535079635,0.04097974000743352,RIPK2,1
WP_COPPER_HOMEOSTASIS,WP_COPPER_HOMEOSTASIS,1/13,54/21728,0.03183979442363272,0.08314496535079635,0.04097974000743352,CCND1,1
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,1/13,56/21728,0.03300087205713398,0.08489888358944736,0.04184419539701684,CCND1,1
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1/13,56/21728,0.03300087205713398,0.08489888358944736,0.04184419539701684,RIPK2,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,1/13,56/21728,0.03300087205713398,0.08489888358944736,0.04184419539701684,TLE3,1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,1/13,57/21728,0.03358092875071417,0.08489888358944736,0.04184419539701684,CCND1,1
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,1/13,57/21728,0.03358092875071417,0.08489888358944736,0.04184419539701684,CCND1,1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1/13,57/21728,0.03358092875071417,0.08489888358944736,0.04184419539701684,CCND1,1
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,CCND1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,CCND1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,PPIF,1
PID_ATF2_PATHWAY,PID_ATF2_PATHWAY,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,CCND1,1
PID_FAK_PATHWAY,PID_FAK_PATHWAY,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,CCND1,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,CCND1,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,ARHGAP17,1
WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,1/13,59/21728,0.03474007870713003,0.08489888358944736,0.04184419539701684,CCND1,1
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1/13,60/21728,0.03531917229598103,0.08489888358944736,0.04184419539701684,MARCHF3,1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1/13,60/21728,0.03531917229598103,0.08489888358944736,0.04184419539701684,CCND1,1
WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,1/13,60/21728,0.03531917229598103,0.08489888358944736,0.04184419539701684,CCND1,1
GRABARCZYK_BCL11B_TARGETS_DN,GRABARCZYK_BCL11B_TARGETS_DN,1/13,61/21728,0.03589794517581091,0.08489888358944736,0.04184419539701684,TSHR,1
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,1/13,61/21728,0.03589794517581091,0.08489888358944736,0.04184419539701684,CCND1,1
PID_AR_PATHWAY,PID_AR_PATHWAY,1/13,61/21728,0.03589794517581091,0.08489888358944736,0.04184419539701684,CCND1,1
PID_TRKR_PATHWAY,PID_TRKR_PATHWAY,1/13,61/21728,0.03589794517581091,0.08489888358944736,0.04184419539701684,CCND1,1
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1/13,61/21728,0.03589794517581091,0.08489888358944736,0.04184419539701684,CHD4,1
REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,1/13,61/21728,0.03589794517581091,0.08489888358944736,0.04184419539701684,CHD4,1
GERHOLD_ADIPOGENESIS_DN,GERHOLD_ADIPOGENESIS_DN,1/13,62/21728,0.03647639750943854,0.08489888358944736,0.04184419539701684,CCND1,1
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,1/13,62/21728,0.03647639750943854,0.08489888358944736,0.04184419539701684,CCND1,1
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/13,62/21728,0.03647639750943854,0.08489888358944736,0.04184419539701684,RIPK2,1
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,1/13,62/21728,0.03647639750943854,0.08489888358944736,0.04184419539701684,RIPK2,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1/13,63/21728,0.0370545294596083,0.08489888358944736,0.04184419539701684,RIPK2,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/13,63/21728,0.0370545294596083,0.08489888358944736,0.04184419539701684,CCND1,1
WILCOX_RESPONSE_TO_PROGESTERONE_DN,WILCOX_RESPONSE_TO_PROGESTERONE_DN,1/13,63/21728,0.0370545294596083,0.08489888358944736,0.04184419539701684,CCND1,1
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,1/13,63/21728,0.0370545294596083,0.08489888358944736,0.04184419539701684,CCND1,1
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,1/13,63/21728,0.0370545294596083,0.08489888358944736,0.04184419539701684,CCND1,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,1/13,64/21728,0.03763234118898884,0.08524295466293684,0.04201377804193332,CCND1,1
PID_ERA_GENOMIC_PATHWAY,PID_ERA_GENOMIC_PATHWAY,1/13,64/21728,0.03763234118898884,0.08524295466293684,0.04201377804193332,CCND1,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/13,64/21728,0.03763234118898884,0.08524295466293684,0.04201377804193332,CCND1,1
KEGG_GLIOMA,KEGG_GLIOMA,1/13,65/21728,0.03820983286017343,0.08590030094129214,0.04233776494202043,CCND1,1
PID_RB_1PATHWAY,PID_RB_1PATHWAY,1/13,65/21728,0.03820983286017343,0.08590030094129214,0.04233776494202043,CCND1,1
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,1/13,66/21728,0.03878700463568063,0.08622538577002609,0.04249798981800265,CCND1,1
PID_HDAC_CLASSI_PATHWAY,PID_HDAC_CLASSI_PATHWAY,1/13,66/21728,0.03878700463568063,0.08622538577002609,0.04249798981800265,CHD4,1
WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,1/13,66/21728,0.03878700463568063,0.08622538577002609,0.04249798981800265,CCND1,1
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/13,67/21728,0.039363856677954834,0.08685219167752496,0.04280692425577714,CCND1,1
ZHANG_RESPONSE_TO_CANTHARIDIN_DN,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,1/13,67/21728,0.039363856677954834,0.08685219167752496,0.04280692425577714,HADHA,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/13,68/21728,0.03994038914936349,0.08685219167752496,0.04280692425577714,CCND1,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/13,68/21728,0.03994038914936349,0.08685219167752496,0.04280692425577714,RIPK2,1
WP_MELANOMA,WP_MELANOMA,1/13,68/21728,0.03994038914936349,0.08685219167752496,0.04280692425577714,CCND1,1
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,1/13,68/21728,0.03994038914936349,0.08685219167752496,0.04280692425577714,TSHR,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/13,69/21728,0.04051660221220077,0.08778597145976832,0.04326715720601151,CCND1,1
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,1/13,70/21728,0.041092496028685255,0.08807638933746875,0.04341029574809233,CCND1,1
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,1/13,70/21728,0.041092496028685255,0.08807638933746875,0.04341029574809233,CCND1,1
PID_AP1_PATHWAY,PID_AP1_PATHWAY,1/13,70/21728,0.041092496028685255,0.08807638933746875,0.04341029574809233,CCND1,1
KEGG_MELANOMA,KEGG_MELANOMA,1/13,71/21728,0.04166807076096124,0.08835995147182561,0.0435500552932779,CCND1,1
LIN_APC_TARGETS,LIN_APC_TARGETS,1/13,71/21728,0.04166807076096124,0.08835995147182561,0.0435500552932779,CCND1,1
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,1/13,71/21728,0.04166807076096124,0.08835995147182561,0.0435500552932779,RIPK2,1
LIN_MELANOMA_COPY_NUMBER_UP,LIN_MELANOMA_COPY_NUMBER_UP,1/13,72/21728,0.04224332657109686,0.08894897637153494,0.04384036856896635,CCND1,1
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,1/13,72/21728,0.04224332657109686,0.08894897637153494,0.04384036856896635,CCND1,1
CHESLER_BRAIN_QTL_CIS,CHESLER_BRAIN_QTL_CIS,1/13,73/21728,0.04281826362108643,0.08921714859027766,0.043972542871462315,CCND1,1
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,1/13,73/21728,0.04281826362108643,0.08921714859027766,0.043972542871462315,CCND1,1
LEE_AGING_CEREBELLUM_DN,LEE_AGING_CEREBELLUM_DN,1/13,73/21728,0.04281826362108643,0.08921714859027766,0.043972542871462315,CCND1,1
REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,1/13,74/21728,0.043392882072849304,0.089479115446772,0.04410165873102652,CHD4,1
REACTOME_SIGNALING_BY_NOTCH1,REACTOME_SIGNALING_BY_NOTCH1,1/13,74/21728,0.043392882072849304,0.089479115446772,0.04410165873102652,TLE3,1
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,1/13,74/21728,0.043392882072849304,0.089479115446772,0.04410165873102652,CCND1,1
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1/13,75/21728,0.04396718208823003,0.09004237975603273,0.04437927535942469,CCND1,1
WP_PEPTIDE_GPCRS,WP_PEPTIDE_GPCRS,1/13,75/21728,0.04396718208823003,0.09004237975603273,0.04437927535942469,TSHR,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/13,76/21728,0.04454116382899864,0.09053243899058944,0.0446208113313942,CCND1,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/13,76/21728,0.04454116382899864,0.09053243899058944,0.0446208113313942,CCND1,1
CARD_MIR302A_TARGETS,CARD_MIR302A_TARGETS,1/13,77/21728,0.045114827456848916,0.09053243899058944,0.0446208113313942,CCND1,1
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,1/13,77/21728,0.045114827456848916,0.09053243899058944,0.0446208113313942,CCND1,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/13,77/21728,0.045114827456848916,0.09053243899058944,0.0446208113313942,CCND1,1
REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,1/13,77/21728,0.045114827456848916,0.09053243899058944,0.0446208113313942,CCND1,1
ROSS_AML_WITH_AML1_ETO_FUSION,ROSS_AML_WITH_AML1_ETO_FUSION,1/13,78/21728,0.04568817313340212,0.0910717584459149,0.044886626236324896,CCND1,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/13,78/21728,0.04568817313340212,0.0910717584459149,0.044886626236324896,RIPK2,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,1/13,79/21728,0.04626120102020437,0.09160330533139804,0.04514861026719144,CCND1,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,1/13,79/21728,0.04626120102020437,0.09160330533139804,0.04514861026719144,CHD4,1
PID_BETA_CATENIN_NUC_PATHWAY,PID_BETA_CATENIN_NUC_PATHWAY,1/13,80/21728,0.04683391127872649,0.091825176867798175,0.04525796430731119,CCND1,1
SU_TESTIS,SU_TESTIS,1/13,80/21728,0.04683391127872649,0.091825176867798175,0.04525796430731119,CLTCL1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,1/13,80/21728,0.04683391127872649,0.091825176867798175,0.04525796430731119,NUDT4,1
BILANGES_SERUM_SENSITIVE_GENES,BILANGES_SERUM_SENSITIVE_GENES,1/13,81/21728,0.04740630407036406,0.0926436922682278,0.04566138678948035,TLE3,1
MCLACHLAN_DENTAL_CARIES_DN,MCLACHLAN_DENTAL_CARIES_DN,1/13,82/21728,0.04797837955643991,0.0927775345949379,0.045727353787330775,NUDT4,1
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1/13,83/21728,0.048550137898201395,0.0927775345949379,0.045727353787330775,CCND1,1
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,1/13,83/21728,0.048550137898201395,0.0927775345949379,0.045727353787330775,PPIF,1
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,1/13,83/21728,0.048550137898201395,0.0927775345949379,0.045727353787330775,RIPK2,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/13,83/21728,0.048550137898201395,0.0927775345949379,0.045727353787330775,CCND1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,1/13,84/21728,0.04912157925682148,0.0927775345949379,0.045727353787330775,CCND1,1
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,1/13,84/21728,0.04912157925682148,0.0927775345949379,0.045727353787330775,CCND1,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/13,84/21728,0.04912157925682148,0.0927775345949379,0.045727353787330775,CCND1,1
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1/13,84/21728,0.04912157925682148,0.0927775345949379,0.045727353787330775,CCND1,1
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,1/13,84/21728,0.04912157925682148,0.0927775345949379,0.045727353787330775,CCND1,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/13,85/21728,0.04969270379339785,0.0927775345949379,0.045727353787330775,CCND1,1
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1/13,85/21728,0.04969270379339785,0.0927775345949379,0.045727353787330775,TLE3,1
COLDREN_GEFITINIB_RESISTANCE_UP,COLDREN_GEFITINIB_RESISTANCE_UP,1/13,86/21728,0.05026351166895493,0.0927775345949379,0.045727353787330775,PPIF,1
ALCALA_APOPTOSIS,ALCALA_APOPTOSIS,1/13,87/21728,0.0508340030444423,0.0927775345949379,0.045727353787330775,HADHA,1
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1/13,87/21728,0.0508340030444423,0.0927775345949379,0.045727353787330775,CHD4,1
WP_ACUTE_VIRAL_MYOCARDITIS,WP_ACUTE_VIRAL_MYOCARDITIS,1/13,87/21728,0.0508340030444423,0.0927775345949379,0.045727353787330775,CCND1,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/13,87/21728,0.0508340030444423,0.0927775345949379,0.045727353787330775,CCND1,1
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,1/13,87/21728,0.0508340030444423,0.0927775345949379,0.045727353787330775,CCND1,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,1/13,88/21728,0.051404178080735496,0.0927775345949379,0.045727353787330775,NUDT4,1
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,1/13,88/21728,0.051404178080735496,0.0927775345949379,0.045727353787330775,ARHGAP17,1
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,1/13,88/21728,0.051404178080735496,0.0927775345949379,0.045727353787330775,CCND1,1
BAELDE_DIABETIC_NEPHROPATHY_UP,BAELDE_DIABETIC_NEPHROPATHY_UP,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,CCND1,1
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,PPIF,1
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,CCND1,1
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,CCND1,1
LI_DCP2_BOUND_MRNA,LI_DCP2_BOUND_MRNA,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,SAP30BP,1
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,CCND1,1
WNT_SIGNALING,WNT_SIGNALING,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,CCND1,1
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,1/13,89/21728,0.05197403693863578,0.0927775345949379,0.045727353787330775,CCND1,1
REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,1/13,90/21728,0.052543579778868366,0.09323756886576641,0.045954091326200666,TLE3,1
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/13,90/21728,0.052543579778868366,0.09323756886576641,0.045954091326200666,CCND1,1
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1/13,91/21728,0.05311280676208685,0.09341605424625864,0.046042061589425136,CCND1,1
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,1/13,91/21728,0.05311280676208685,0.09341605424625864,0.046042061589425136,CCND1,1
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,1/13,91/21728,0.05311280676208685,0.09341605424625864,0.046042061589425136,RIPK2,1
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/13,92/21728,0.05368171804886768,0.0935908670356352,0.04612822173909145,CCND1,1
REACTOME_EPH_EPHRIN_SIGNALING,REACTOME_EPH_EPHRIN_SIGNALING,1/13,92/21728,0.05368171804886768,0.0935908670356352,0.04612822173909145,CLTCL1,1
REACTOME_HDACS_DEACETYLATE_HISTONES,REACTOME_HDACS_DEACETYLATE_HISTONES,1/13,92/21728,0.05368171804886768,0.0935908670356352,0.04612822173909145,CHD4,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/13,93/21728,0.054250313799716565,0.09403387725284205,0.04634656861608128,NUDT4,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/13,93/21728,0.054250313799716565,0.09403387725284205,0.04634656861608128,CCND1,1
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,1/13,94/21728,0.054818594175062296,0.09447123722388258,0.04656213065074304,ARHGAP17,1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1/13,94/21728,0.054818594175062296,0.09447123722388258,0.04656213065074304,RIPK2,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/13,95/21728,0.0553865593352606,0.09517575426001677,0.0469093666481336,TSHR,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/13,96/21728,0.05595420944059226,0.09560176355849764,0.04711933426576191,NUDT4,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/13,96/21728,0.05595420944059226,0.09560176355849764,0.04711933426576191,CCND1,1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/13,97/21728,0.05652154465126502,0.09602239687913774,0.04732665221995875,RIPK2,1
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1/13,97/21728,0.05652154465126502,0.09602239687913774,0.04732665221995875,RIPK2,1
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,1/13,98/21728,0.057088565127411894,0.0967109403574853,0.04766601531437403,CCND1,1
BRUINS_UVC_RESPONSE_MIDDLE,BRUINS_UVC_RESPONSE_MIDDLE,1/13,99/21728,0.05765527102909196,0.0973950623598785,0.04800319919163172,SAP30BP,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/13,101/21728,0.05878773974891982,0.09902836160522269,0.04880820498057094,CCND1,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/13,102/21728,0.059353502886814624,0.0997005469840313,0.04913950564254316,RIPK2,1
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1/13,103/21728,0.05991895208974041,0.1000880819823038,0.049330510394376116,RIPK2,1
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,1/13,103/21728,0.05991895208974041,0.1000880819823038,0.049330510394376116,CCND1,1
REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,1/13,104/21728,0.060484087517385876,0.10075065274483776,0.049657072291065966,CHD4,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,1/13,105/21728,0.061048909329366796,0.10112811019102864,0.04984311010999476,CCND1,1
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/13,105/21728,0.061048909329366796,0.10112811019102864,0.04984311010999476,CLTCL1,1
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,1/13,106/21728,0.06161341768522466,0.10178128114852028,0.05016503911562346,CCND1,1
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,1/13,107/21728,0.062177612744428123,0.10214893522298905,0.050346245137188765,TSHR,1
REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,1/13,107/21728,0.062177612744428123,0.10214893522298905,0.050346245137188765,SAP30BP,1
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,1/13,108/21728,0.06274149466637102,0.10251205959150238,0.05052521859817051,TSHR,1
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,1/13,108/21728,0.06274149466637102,0.10251205959150238,0.05052521859817051,CCND1,1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,1/13,109/21728,0.06330506361037369,0.10287072836685725,0.05070199602661509,CHD4,1
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,1/13,109/21728,0.06330506361037369,0.10287072836685725,0.05070199602661509,PPIF,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/13,110/21728,0.06386831973568274,0.10322501405929264,0.05087661316071456,CCND1,1
LEE_EARLY_T_LYMPHOCYTE_UP,LEE_EARLY_T_LYMPHOCYTE_UP,1/13,110/21728,0.06386831973568274,0.10322501405929264,0.05087661316071456,TSHR,1
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1/13,111/21728,0.06443126320147241,0.10385416548377494,0.051186703635727845,CCND1,1
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,1/13,112/21728,0.06499389416684143,0.10447943202089024,0.05149487936252293,SAP30BP,1
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/13,113/21728,0.0655562127908157,0.10510084517133454,0.0518011558668785,TLE3,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1/13,114/21728,0.06611821923234773,0.1051561039918722,0.05182839133554693,TLE3,1
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/13,114/21728,0.06611821923234773,0.1051561039918722,0.05182839133554693,CCND1,1
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,1/13,114/21728,0.06611821923234773,0.1051561039918722,0.05182839133554693,CCND1,1
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,1/13,115/21728,0.06667991365031667,0.10576813889360576,0.05213004557333148,CCND1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,1/13,116/21728,0.06724129620352759,0.10637644214208862,0.05242986058754588,MARCHF3,1
WP_WNT_SIGNALING,WP_WNT_SIGNALING,1/13,117/21728,0.06780236705071252,0.10698104352592636,0.052727851060129165,CCND1,1
BURTON_ADIPOGENESIS_5,BURTON_ADIPOGENESIS_5,1/13,118/21728,0.06836312635052932,0.107018716119415,0.05274641878795319,PPIF,1
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,1/13,118/21728,0.06836312635052932,0.107018716119415,0.05274641878795319,SAP30BP,1
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,1/13,118/21728,0.06836312635052932,0.107018716119415,0.05274641878795319,CCND1,1
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,1/13,119/21728,0.06892357426156281,0.10733410783441293,0.05290186620953287,CCND1,1
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,1/13,119/21728,0.06892357426156281,0.10733410783441293,0.05290186620953287,CCND1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1/13,120/21728,0.06948371094232564,0.10792534842470321,0.05319327153479476,CCND1,1
KEGG_LYSOSOME,KEGG_LYSOSOME,1/13,121/21728,0.07004353655125506,0.10825801191163181,0.0533572317114186,CLTCL1,1
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,1/13,122/21728,0.0706030512467164,0.10825801191163181,0.0533572317114186,SAP30BP,1
HOLLERN_EMT_BREAST_TUMOR_DN,HOLLERN_EMT_BREAST_TUMOR_DN,1/13,122/21728,0.0706030512467164,0.10825801191163181,0.0533572317114186,PPIF,1
WP_CELL_CYCLE,WP_CELL_CYCLE,1/13,122/21728,0.0706030512467164,0.10825801191163181,0.0533572317114186,CCND1,1
WP_FRAGILE_X_SYNDROME,WP_FRAGILE_X_SYNDROME,1/13,122/21728,0.0706030512467164,0.10825801191163181,0.0533572317114186,CLTCL1,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/13,123/21728,0.07116225518700092,0.10883639028600141,0.05364229762379932,CCND1,1
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,1/13,124/21728,0.07172114853032796,0.10941134393146969,0.053925675586712754,RIPK2,1
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,1/13,125/21728,0.07227973143484134,0.10970375481734802,0.05406979642467427,CCND1,1
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,1/13,125/21728,0.07227973143484134,0.10970375481734802,0.05406979642467427,MARCHF3,1
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1/13,126/21728,0.07283800405861296,0.10999274350265291,0.05421223055930789,RIPK2,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/13,126/21728,0.07283800405861296,0.10999274350265291,0.05421223055930789,TLE3,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,1/13,128/21728,0.0739536190958553,0.1111162417570891,0.054765970237607736,MARCHF3,1
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1/13,128/21728,0.0739536190958553,0.1111162417570891,0.054765970237607736,HADHA,1
GAL_LEUKEMIC_STEM_CELL_UP,GAL_LEUKEMIC_STEM_CELL_UP,1/13,129/21728,0.07451096182510308,0.11167307060504171,0.055040415013926564,CCND1,1
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1/13,130/21728,0.07506799490516558,0.11221732421653105,0.05530866182120877,PPIF,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1/13,131/21728,0.07562471849374919,0.11221732421653105,0.05530866182120877,CHD4,1
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1/13,131/21728,0.07562471849374919,0.11221732421653105,0.05530866182120877,CLTCL1,1
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,1/13,131/21728,0.07562471849374919,0.11221732421653105,0.05530866182120877,CLTCL1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/13,132/21728,0.07618113274848748,0.11248473428048275,0.05544046047973099,CCND1,1
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,1/13,132/21728,0.07618113274848748,0.11248473428048275,0.05544046047973099,RIPK2,1
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1/13,133/21728,0.07673723782694053,0.11274906196685612,0.05557073992381573,TSHR,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,1/13,133/21728,0.07673723782694053,0.11274906196685612,0.05557073992381573,CCND1,1
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,1/13,134/21728,0.07729303388659559,0.1132873388828043,0.05583604099134873,CHD4,1
TSENG_IRS1_TARGETS_DN,TSENG_IRS1_TARGETS_DN,1/13,135/21728,0.07784852108486684,0.11354491611890334,0.05596299333443573,TLE3,1
YEGNASUBRAMANIAN_PROSTATE_CANCER,YEGNASUBRAMANIAN_PROSTATE_CANCER,1/13,135/21728,0.07784852108486684,0.11354491611890334,0.05596299333443573,SLC25A21,1
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/13,138/21728,0.07951313108443125,0.11540983589439294,0.05688215815953182,PPIF,1
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,1/13,138/21728,0.07951313108443125,0.11540983589439294,0.05688215815953182,CCND1,1
REACTOME_PTEN_REGULATION,REACTOME_PTEN_REGULATION,1/13,139/21728,0.08006738440985472,0.11593291979925696,0.057139971032902574,CHD4,1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1/13,140/21728,0.08062132965987479,0.11617242201591596,0.05725801472356359,SAP30BP,1
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,1/13,140/21728,0.08062132965987479,0.11617242201591596,0.05725801472356359,RIPK2,1
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,1/13,141/21728,0.08117496699146698,0.11668901505023378,0.05751262843524989,RIPK2,1
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/13,142/21728,0.08172829656153757,0.11720268907385964,0.05776580345129502,CCND1,1
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,1/13,144/21728,0.08283403304436743,0.11850419081466919,0.058407275881195875,TSHR,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/13,145/21728,0.08338644027057285,0.11900976439571018,0.05865645842421907,CLTCL1,1
ELVIDGE_HYPOXIA_DN,ELVIDGE_HYPOXIA_DN,1/13,147/21728,0.08449033347563661,0.12029814147245405,0.05929146208816605,PPIF,1
RODWELL_AGING_KIDNEY_DN,RODWELL_AGING_KIDNEY_DN,1/13,148/21728,0.08504181976750547,0.12050949815395325,0.059395633661515415,NUDT4,1
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1/13,148/21728,0.08504181976750547,0.12050949815395325,0.059395633661515415,NUDT4,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/13,149/21728,0.08559299939415133,0.1210038147463416,0.05963926796158361,CCND1,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/13,150/21728,0.08614387251189926,0.12112914646646285,0.05970104032848019,TLE3,1
WHITFIELD_CELL_CYCLE_S,WHITFIELD_CELL_CYCLE_S,1/13,150/21728,0.08614387251189926,0.12112914646646285,0.05970104032848019,SAP30BP,1
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,1/13,151/21728,0.08669443927700016,0.12112914646646285,0.05970104032848019,CCND1,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/13,151/21728,0.08669443927700016,0.12112914646646285,0.05970104032848019,CCND1,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/13,151/21728,0.08669443927700016,0.12112914646646285,0.05970104032848019,NUDT4,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/13,155/21728,0.08889364593343374,0.12305185247266985,0.06064868630936025,CCND1,1
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,1/13,155/21728,0.08889364593343374,0.12305185247266985,0.06064868630936025,ARHGAP17,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/13,155/21728,0.08889364593343374,0.12305185247266985,0.06064868630936025,RIPK2,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,1/13,155/21728,0.08889364593343374,0.12305185247266985,0.06064868630936025,CCND1,1
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,1/13,156/21728,0.08944268327654181,0.12324130092021199,0.06074205995011329,CHD4,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/13,156/21728,0.08944268327654181,0.12324130092021199,0.06074205995011329,CCND1,1
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,1/13,158/21728,0.09053984186853326,0.124466265373294,0.06134580937250893,CCND1,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1/13,160/21728,0.09163578003949946,0.12539633058036767,0.061804211516463564,TLE3,1
REACTOME_REGULATION_OF_TP53_ACTIVITY,REACTOME_REGULATION_OF_TP53_ACTIVITY,1/13,160/21728,0.09163578003949946,0.12539633058036767,0.061804211516463564,CHD4,1
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,1/13,161/21728,0.09218329185605545,0.12574339778301216,0.06197527086647317,PPIF,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/13,162/21728,0.09273049903396047,0.12574339778301216,0.06197527086647317,CCND1,1
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,1/13,162/21728,0.09273049903396047,0.12574339778301216,0.06197527086647317,NUDT4,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/13,162/21728,0.09273049903396047,0.12574339778301216,0.06197527086647317,HADHA,1
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,1/13,164/21728,0.09382400009528169,0.1266518105123667,0.062423001132657426,MARCHF3,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/13,164/21728,0.09382400009528169,0.1266518105123667,0.062423001132657426,PPIF,1
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,1/13,166/21728,0.09491628446567546,0.12755042272016612,0.06286590100624277,CCND1,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,1/13,166/21728,0.09491628446567546,0.12755042272016612,0.06286590100624277,CCND1,1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,1/13,167/21728,0.09546197077965146,0.12770975061796772,0.06294442910232523,ARHGAP17,1
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,1/13,167/21728,0.09546197077965146,0.12770975061796772,0.06294442910232523,TLE3,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/13,168/21728,0.09600735338620303,0.1281526726003335,0.06316273249092305,CCND1,1
SMID_BREAST_CANCER_LUMINAL_B_UP,SMID_BREAST_CANCER_LUMINAL_B_UP,1/13,169/21728,0.09655243244028378,0.12859321737035567,0.06337986422055904,CCND1,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/13,170/21728,0.09709720809677436,0.1290314009819357,0.06359583220373526,SAP30BP,1
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,1/13,171/21728,0.0976416805104835,0.12946723934649473,0.06381064428272933,CHD4,1
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,1/13,173/21728,0.0987297162284353,0.1306202882845228,0.06437894863521632,TLE3,1
VILLANUEVA_LIVER_CANCER_KRT19_UP,VILLANUEVA_LIVER_CANCER_KRT19_UP,1/13,175/21728,0.09981654083117553,0.13176664771974164,0.06494395592594203,MARCHF3,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/13,177/21728,0.10090215555459459,0.13287138095161902,0.06548844686930705,HADHA,1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,1/13,178/21728,0.10144450959745976,0.13287138095161902,0.06548844686930705,CCND1,1
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,1/13,179/21728,0.10198656163343334,0.13287138095161902,0.06548844686930705,TLE3,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1/13,179/21728,0.10198656163343334,0.13287138095161902,0.06548844686930705,MARCHF3,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1/13,179/21728,0.10198656163343334,0.13287138095161902,0.06548844686930705,CCND1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1/13,179/21728,0.10198656163343334,0.13287138095161902,0.06548844686930705,CCND1,1
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,1/13,181/21728,0.10306976030128945,0.13382143095094762,0.06595669893727396,CLTCL1,1
KEGG_HUNTINGTONS_DISEASE,KEGG_HUNTINGTONS_DISEASE,1/13,182/21728,0.10361090724128552,0.13382143095094762,0.06595669893727396,CLTCL1,1
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,1/13,182/21728,0.10361090724128552,0.13382143095094762,0.06595669893727396,CCND1,1
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1/13,182/21728,0.10361090724128552,0.13382143095094762,0.06595669893727396,PPIF,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,1/13,184/21728,0.1046922971031573,0.13463654552190985,0.06635844524931307,ARHGAP17,1
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,1/13,184/21728,0.1046922971031573,0.13463654552190985,0.06635844524931307,ARHGAP17,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/13,186/21728,0.1057724826330323,0.13573378672650924,0.06689924358990071,CCND1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,1/13,190/21728,0.10792924561402939,0.13820490123595197,0.06811718420360245,SAP30BP,1
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,1/13,192/21728,0.10900582552091653,0.1392852214989489,0.06864964270323129,MARCHF3,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,1/13,193/21728,0.1095436656150951,0.13967401287383127,0.06884126668662693,CCND1,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1/13,195/21728,0.11061844685074618,0.1407443217377579,0.06936879085825068,CHD4,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,1/13,197/21728,0.11169203050305987,0.14180856526715457,0.06989332560254055,CCND1,1
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,1/13,198/21728,0.11222837361779925,0.14218764284627955,0.07008016193796564,CCND1,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,1/13,199/21728,0.11276441779536406,0.14256473962289157,0.07026602199332802,CCND1,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/13,200/21728,0.11330016318849245,0.1426389422878284,0.0703025943330258,PPIF,1
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,1/13,200/21728,0.11330016318849245,0.1426389422878284,0.0703025943330258,SAP30BP,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,1/13,201/21728,0.11383560994985209,0.14301196376052847,0.07048644578938211,TLE3,1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1/13,202/21728,0.11437075823204002,0.14308308247439316,0.07052149813911299,CHD4,1
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,1/13,202/21728,0.11437075823204002,0.14308308247439316,0.07052149813911299,CCND1,1
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,1/13,205/21728,0.11597441372847461,0.14478642883012072,0.07136102811553213,MARCHF3,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,1/13,207/21728,0.11704202779132122,0.145511710227048,0.07171849826363923,PPIF,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/13,207/21728,0.11704202779132122,0.145511710227048,0.07171849826363923,MARCHF3,1
GROSS_HYPOXIA_VIA_ELK3_UP,GROSS_HYPOXIA_VIA_ELK3_UP,1/13,209/21728,0.11810845159378047,0.14653289222630855,0.07222180922965392,CCND1,1
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,1/13,210/21728,0.11864121752757284,0.14688912646270924,0.07239738674451433,RIPK2,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,1/13,211/21728,0.11917368635237757,0.1469399266777769,0.07242242469596467,CCND1,1
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,1/13,211/21728,0.11917368635237757,0.1469399266777769,0.07242242469596467,HADHA,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/13,215/21728,0.1213005935984387,0.1492546398598073,0.07356327963518051,NUDT4,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/13,217/21728,0.122362268513307,0.15025182047424557,0.07405476101529443,CCND1,1
WONG_MITOCHONDRIA_GENE_MODULE,WONG_MITOCHONDRIA_GENE_MODULE,1/13,218/21728,0.12289266182413983,0.1505938765795812,0.0742233505408955,PPIF,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1/13,221/21728,0.12448206698677011,0.15222960339077407,0.07502955280657762,NUDT4,1
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,1/13,223/21728,0.12554019296600638,0.1522779622589692,0.07505338748901845,RIPK2,1
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,1/13,223/21728,0.12554019296600638,0.1522779622589692,0.07505338748901845,PPIF,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1/13,223/21728,0.12554019296600638,0.1522779622589692,0.07505338748901845,TSHR,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/13,223/21728,0.12554019296600638,0.1522779622589692,0.07505338748901845,RIPK2,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,1/13,224/21728,0.1260688131702119,0.15260961594288808,0.07521684996304995,PPIF,1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,1/13,225/21728,0.12659713838546405,0.1529395732414293,0.07537947633796903,NUDT4,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,1/13,226/21728,0.12712516876266677,0.15326784459692486,0.07554127176049809,CCND1,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1/13,228/21728,0.1281803456061863,0.15422906775150788,0.07601503075237141,PPIF,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,1/13,230/21728,0.12923434490659536,0.1551850165745864,0.07648619017934201,CCND1,1
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1/13,232/21728,0.13028716786859718,0.15582345277084222,0.07680085684885728,TLE3,1
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,1/13,232/21728,0.13028716786859718,0.15582345277084222,0.07680085684885728,TLE3,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1/13,237/21728,0.13291408668883042,0.1586479517762886,0.07819297042309596,CCND1,1
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,1/13,238/21728,0.1334385907543948,0.15895672763172927,0.07834515707953564,TSHR,1
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,1/13,239/21728,0.1339628019372795,0.15926392755167623,0.07849656700311448,PPIF,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/13,240/21728,0.1344867203874085,0.1595695610945839,0.07864720490491726,HADHA,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,1/13,241/21728,0.13501034625463493,0.15987363774311225,0.07879707545867178,CCND1,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,1/13,242/21728,0.1355336796887433,0.16017616690487846,0.07894618330111947,RIPK2,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/13,243/21728,0.1360567208394482,0.1604771579131953,0.07909453303237932,PPIF,1
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,1/13,244/21728,0.13657946985639458,0.16077662002780305,0.07924212921630851,TLE3,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,1/13,248/21728,0.13866754757704836,0.16291393605319238,0.08029555024624867,CCND1,1
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,1/13,250/21728,0.13970983752046884,0.16349605251906138,0.08058245855542544,PPIF,1
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,1/13,250/21728,0.13970983752046884,0.16349605251906138,0.08058245855542544,CHD4,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,1/13,251/21728,0.14023054578530902,0.16378489527268514,0.08072482076456934,CCND1,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,1/13,257/21728,0.14334869086635793,0.1671004232711151,0.08235894827655735,MARCHF3,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,1/13,258/21728,0.14386736568442637,0.16737876396748438,0.08249613432651934,MARCHF3,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/13,262/21728,0.14593916746739244,0.16913105066957496,0.08335978557908993,HADHA,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/13,262/21728,0.14593916746739244,0.16913105066957496,0.08335978557908993,CHD4,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,1/13,266/21728,0.14800634038962224,0.17119495464795764,0.08437702394196116,PPIF,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1/13,269/21728,0.14955368809601643,0.17265078278265988,0.08509455937184435,TLE3,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,1/13,270/21728,0.15006889393294964,0.1729117506202387,0.08522318284398317,CCND1,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/13,271/21728,0.15058381165029822,0.17317138339784294,0.08535114830381275,TLE3,1
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,1/13,272/21728,0.15109844139576867,0.17342968897249458,0.08547845962383116,TSHR,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/13,274/21728,0.15212683756154843,0.1742755725321953,0.085895371077301,ARHGAP17,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,1/13,276/21728,0.15315408361055738,0.17511690630805607,0.08631004007438074,CHD4,1
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,1/13,280/21728,0.15520513007382974,0.17712341180181332,0.08729898839026182,TLE3,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1/13,281/21728,0.15571717470778368,0.17736927709572314,0.08742016825700137,CCND1,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/13,285/21728,0.1577624897266915,0.17935735524061125,0.08840003426750774,NUDT4,1
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,1/13,290/21728,0.16031270159567668,0.1819108075032536,0.08965855676977824,TLE3,1
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1/13,292/21728,0.16133078906831655,0.18237393546853173,0.08988681910084297,NUDT4,1
MANALO_HYPOXIA_DN,MANALO_HYPOXIA_DN,1/13,292/21728,0.16133078906831655,0.18237393546853173,0.08988681910084297,PPIF,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,1/13,295/21728,0.16285578399817768,0.1836304527027658,0.09050611997319914,TLE3,1
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,1/13,296/21728,0.16336354655162444,0.1836304527027658,0.09050611997319914,NUDT4,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,1/13,296/21728,0.16336354655162444,0.1836304527027658,0.09050611997319914,PPIF,1
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,1/13,297/21728,0.16387102480352966,0.1838552961210333,0.09061693876762775,RIPK2,1
MUELLER_PLURINET,MUELLER_PLURINET,1/13,299/21728,0.1648851289863461,0.18464664257272467,0.09100697046358548,CCND1,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/13,303/21728,0.16690993214961491,0.18656474658966304,0.09195234825753504,CCND1,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/13,307/21728,0.1689302028075862,0.18811966718610157,0.09271872348549277,CHD4,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1/13,307/21728,0.1689302028075862,0.18811966718610157,0.09271872348549277,PPIF,1
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,1/13,308/21728,0.16943456335861107,0.18833061131682047,0.09282269172453747,TSHR,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,1/13,309/21728,0.16993864135470538,0.18854045923954327,0.09292611967448006,MARCHF3,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1/13,317/21728,0.17396111074490006,0.19264582263972266,0.09494953412977002,PPIF,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,1/13,319/21728,0.1749639126850826,0.19339818814358484,0.09532035324802633,ARHGAP17,1
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,1/13,321/21728,0.17596559077541452,0.1941465374237968,0.0956891928862227,CCND1,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/13,322/21728,0.17646600873775975,0.1941756979999847,0.0957035652877939,CCND1,1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,1/13,323/21728,0.17696614617055462,0.1941756979999847,0.0957035652877939,PPIF,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,1/13,323/21728,0.17696614617055462,0.1941756979999847,0.0957035652877939,CCND1,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,1/13,325/21728,0.17796558002408225,0.19491468288351868,0.09606778948668408,CCND1,1
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,1/13,329/21728,0.17996108771523034,0.1963808949885178,0.09679044287411545,NUDT4,1
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,1/13,329/21728,0.17996108771523034,0.1963808949885178,0.09679044287411545,TLE3,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1/13,331/21728,0.1809571638546259,0.19710816755021182,0.09714889440953937,TSHR,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/13,333/21728,0.18195212305595976,0.1978315810681162,0.09750544393429424,HADHA,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,1/13,334/21728,0.1824491841637077,0.19801200023574808,0.09759436730506861,SAP30BP,1
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,1/13,335/21728,0.18294596646743178,0.19819146367305107,0.09768281962410545,CCND1,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1/13,336/21728,0.18344247011048853,0.19836997671984113,0.09777080352324506,PPIF,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,1/13,337/21728,0.18393869523616957,0.1985475446773094,0.09785832161529068,ARHGAP17,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1/13,339/21728,0.1849303105082286,0.19925824447553284,0.09820860491665058,MARCHF3,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,1/13,341/21728,0.1859208134285919,0.1999651914213992,0.09855703854601616,CCND1,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,1/13,345/21728,0.1878984867888147,0.20172943464939175,0.09942658282314679,CCND1,1
RICKMAN_METASTASIS_UP,RICKMAN_METASTASIS_UP,1/13,351/21728,0.1908566827545225,0.2045381653892553,0.1008109246769785,NUDT4,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,1/13,357/21728,0.19380492917566916,0.2073262033042042,0.10218506763805174,NUDT4,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1/13,359/21728,0.1947854722787128,0.207632285958414,0.10233592689377913,CCND1,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/13,359/21728,0.1947854722787128,0.207632285958414,0.10233592689377913,MARCHF3,1
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,1/13,361/21728,0.19576491442117194,0.20830501570081997,0.10266749585676746,SAP30BP,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,1/13,366/21728,0.19820871050916156,0.20993037907167927,0.10346859028352438,NUDT4,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/13,366/21728,0.19820871050916156,0.20993037907167927,0.10346859028352438,CHD4,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,1/13,367/21728,0.1986966464123252,0.20993037907167927,0.10346859028352438,CCND1,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1/13,367/21728,0.1986966464123252,0.20993037907167927,0.10346859028352438,RIPK2,1
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,1/13,371/21728,0.20064565035164528,0.21161569472713207,0.10429923345114765,CCND1,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/13,374/21728,0.2021045305979351,0.21277906566472746,0.10487262521760904,SLC25A21,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1/13,377/21728,0.20356095274832253,0.21356043814648573,0.10525774103329698,TSHR,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1/13,377/21728,0.20356095274832253,0.21356043814648573,0.10525774103329698,TLE3,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/13,384/21728,0.2069497331567106,0.21673544733399816,0.10682261090216422,CCND1,1
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,1/13,385/21728,0.20743275665132133,0.21686151831729047,0.10688474763041954,PPIF,1
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,1/13,401/21728,0.21512429303103664,0.22451016969033144,0.11065454587800176,RIPK2,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/13,403/21728,0.21608087515716745,0.22511561558185741,0.1109529525839114,TLE3,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,1/13,405/21728,0.21703638101077993,0.22571783625121114,0.11124976967142954,CHD4,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,1/13,407/21728,0.21799081170200552,0.2263168496489571,0.11154500598786832,CCND1,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,1/13,411/21728,0.21989645203261854,0.22789961579810378,0.11232510548049476,TSHR,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/13,419/21728,0.22369487947553945,0.23143518672382804,0.11406768576425252,PPIF,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1/13,428/21728,0.22794769941575843,0.23542784844667278,0.11603555283412849,ARHGAP17,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/13,433/21728,0.23030107412967282,0.23703965977546362,0.11682996785271926,HADHA,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,1/13,433/21728,0.23030107412967282,0.23703965977546362,0.11682996785271926,CCND1,1
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,1/13,438/21728,0.23264782553165797,0.23904364204111933,0.11781767254270978,CCND1,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,1/13,441/21728,0.23405270429473335,0.24007464351329422,0.11832582324189825,TLE3,1
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,1/13,445/21728,0.23592218286441213,0.24116489803917682,0.11886317805134576,CCND1,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,1/13,445/21728,0.23592218286441213,0.24116489803917682,0.11886317805134576,TLE3,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,1/13,446/21728,0.236388893930651,0.24122962213400906,0.11889507867896944,CCND1,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1/13,449/21728,0.2377874487242072,0.24224343157934564,0.11939475592715508,PPIF,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,1/13,450/21728,0.2382531079735415,0.24230503157853367,0.11942511677871753,ARHGAP17,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/13,452/21728,0.23918363876452708,0.24283839725159118,0.1196879972371863,SAP30BP,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1/13,454/21728,0.24011312018341047,0.24295709961028672,0.11974650218426384,TLE3,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1/13,454/21728,0.24011312018341047,0.24295709961028672,0.11974650218426384,RIPK2,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,1/13,463/21728,0.2442828296529701,0.2463425499704488,0.12141509239874258,TSHR,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1/13,463/21728,0.2442828296529701,0.2463425499704488,0.12141509239874258,CHD4,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,1/13,472/21728,0.24843140987735957,0.2501043486644125,0.12326917378284723,CCND1,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,1/13,485/21728,0.2543867002179525,0.2552403468629792,0.12580055821445904,CCND1,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1/13,485/21728,0.2543867002179525,0.2552403468629792,0.12580055821445904,CHD4,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1/13,493/21728,0.25802981188559426,0.25846202262577117,0.12738842868371048,NUDT4,1
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,1/13,495/21728,0.2589380188011853,0.2589380188011853,0.12762303338203113,CHD4,1
